A. Winge-Main
Impact in
-
- Cutaneous Melanoma Detection and Management
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
-
- Immunotherapy and Immune Responses
Papers in
- Oncology 8
- Cutaneous Melanoma Detection and Management 4
- CAR-T cell therapy research 4
- Cancer Immunotherapy and Biomarkers 3
-
- Immunotherapy and Immune Responses 2
- Co-authors
- Jan Gunnar Fjeld (1 shared paper)Sophie D. Fosså (1 shared paper)Wolfgang A. Lilleby (1 shared paper)Sébastien Wälchli (2 shared papers)Else-Marit Inderberg-Suso (2 shared papers)Pierre Dillard (1 shared paper)Hakan Köksal (1 shared paper)Gunnar Kvalheim (1 shared paper)
- Journals
- Molecular Therapy (1 paper)Future Oncology (1 paper)Clinical Oncology (1 paper)Acta Oncologica (1 paper)Scandinavian Journal of Immunology (1 paper)
- Partner nations
- NorwayUnited Kingdom
In The Last Decade
A. Winge-Main
8 papers receiving 371 citations
A. Winge-Main's Hit Papers
Peers
Comparison fields: 5 of 40
- Oncology 246
- Immunology 85
- Pulmonary and Respiratory Medicine 46
- Cancer Research 19
- Molecular Biology 94
Countries citing papers authored by A. Winge-Main
This map shows the geographic impact of A. Winge-Main's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Winge-Main with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Winge-Main more than expected).
Fields of papers citing papers by A. Winge-Main
This network shows the impact of papers produced by A. Winge-Main. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Winge-Main. The network helps show where A. Winge-Main may publish in the future.
Co-authors
The 24 scholars most cited alongside A. Winge-Main, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): distant metastasis-free survival results from a double-blind, randomised, controlled, phase 3 trial Hit paper breakdown → | 2021 | 296 |
| 2 | 2010 | 38 | |
| 3 | 2020 | 24 | |
| 4 | 2020 | 9 | |
| 5 | 2023 | 6 | |
| 6 | 2021 | 2 | |
| 7 | 2024 | 1 | |
| 8 | 2020 | 1 | |
| 9 | 2022 | 0 | |
| 10 | 2024 | 0 |
About A. Winge-Main
A. Winge-Main is a scholar working on Oncology, Immunology, Biophysics, Dermatology and Genetics, having authored 10 papers that have together received 377 indexed citations. Recurring topics across this work include Cutaneous Melanoma Detection and Management (4 papers), CAR-T cell therapy research (4 papers), Cancer Immunotherapy and Biomarkers (3 papers), Immunotherapy and Immune Responses (2 papers), Melanoma and MAPK Pathways (2 papers), Adrenal Hormones and Disorders (1 paper), Glioma Diagnosis and Treatment (1 paper) and Renal cell carcinoma treatment (1 paper). The work is most often cited by research in Oncology (246 citations), Immunology (85 citations), Pulmonary and Respiratory Medicine (46 citations), Cancer Research (19 citations) and Molecular Biology (94 citations). A. Winge-Main has collaborated with scholars based in Norway and United Kingdom. Frequent co-authors include Jan Gunnar Fjeld, Sophie D. Fosså, Wolfgang A. Lilleby, Sébastien Wälchli, Else-Marit Inderberg-Suso, Pierre Dillard, Hakan Köksal, Gunnar Kvalheim, Marit Renée Myhre and Sólrún Melkorka Maggadóttir. Their work appears in journals such as Molecular Therapy, Future Oncology, Clinical Oncology, Acta Oncologica and Scandinavian Journal of Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.